Mode
Text Size
Log in / Sign up

Early mobilization reduces ICU-acquired weakness and delirium in patients with acute respiratory distress syndromeEarly Movement Helps ARDS Patients in Intensive Care

AI-generated summary of the cited source, checked by automated accuracy review. How we work

Key Takeaway
Consider early mobilization to reduce ICU-acquired weakness, delirium, and mechanical ventilation duration in ARDS.

This meta-analysis synthesized data from 7 RCTs to evaluate the impact of early mobilization on outcomes in patients with acute respiratory distress syndrome (ARDS). The analysis focused on secondary outcomes including intensive care unit-acquired weakness (ICU-AW), delirium, and the duration of mechanical ventilation.

The meta-analysis reported a significant reduction in the incidence of ICU-acquired weakness (OR = 0.35; 95% CI 0.19, 0.64; P = 0.0006) and a reduction in the incidence of delirium (OR = 0.51; 95% CI 0.28, 0.91; P = 0.02) for patients receiving early mobilization compared to conventional treatment. Additionally, the duration of mechanical ventilation was shortened by a mean difference of -2.40 (95% CI -2.96, -1.84).

No specific limitations or safety data were reported. The results suggest that early mobilization may be a viable intervention to improve functional outcomes and reduce complications in the ARDS population. However, clinical application should be weighed against the specific needs of the individual patient in the intensive care setting.

How this fits prior evidence

This meta-analysis addresses a gap in the management of acute respiratory distress syndrome (ARDS) by evaluating early mobilization. While previous coverage noted that aerosol therapy for ARDS lacks established clinical benefit beyond bench-derived evidence, this finding provides evidence for a different intervention, early mobilization, to improve outcomes like delirium and ICU-acquired weakness. It does not directly relate to the findings on sNIPPV in preterm infants, probiotic supplementation, glymphatic system failure, or corticosteroid use for pneumonia.

A new review of seven randomized trials looked at early mobilization for patients with acute respiratory distress syndrome (ARDS). Early mobilization means getting patients moving—such as sitting up or walking—sooner than usual while they are in intensive care.

The review found that early mobilization was linked to a lower chance of intensive care unit-acquired weakness. Patients who moved early had about a 65% lower chance of developing this weakness compared to those who received conventional treatment.

Early mobilization was also tied to a lower chance of delirium, with about a 49% lower chance. Delirium is a state of confusion that is common in intensive care.

In addition, patients who received early mobilization spent about 2.4 fewer days on a mechanical ventilator (breathing machine).

The review did not report information on side effects, funding, or study limits. Because the findings come from a small number of trials, more research is needed to confirm these benefits. Still, the results suggest that early mobilization may be a helpful approach for ARDS patients in intensive care.

What this means for you:
Early mobilization may reduce weakness, delirium, and time on a breathing machine for ARDS patients.

Common questions

What is early mobilization for ARDS patients?

Early mobilization means getting patients moving sooner than usual, even while they are still very sick in the ICU. In the studies reviewed, it was compared with conventional treatment. The goal is to help patients avoid problems that come from lying still for a long time, like muscle weakness and confusion.

How much does early mobilization help?

In this meta-analysis of 7 randomized trials, early mobilization was linked to less ICU-acquired weakness (odds ratio 0.35), less delirium (odds ratio 0.51), and about 2.4 fewer days on a mechanical ventilator. These are group results, so individual experiences may differ.

Is early mobilization safe for ARDS patients?

The review did not report safety information like adverse events or how well patients tolerated the treatment. That means we cannot say from this analysis alone how safe it is. If you or a loved one is in the ICU, ask the care team about the risks and benefits for your specific situation.

Who does this apply to?

The analysis included patients with acute respiratory distress syndrome, or ARDS. It does not tell us about other groups. If you are wondering whether early mobilization could help someone you know, talk with their doctor.

Study Details

Study typeMeta analysis
EvidenceLevel 1
PublishedSep 2026
View Original Abstract ↓
ObjectiveTo evaluate the effect of early mobilization in patients with acute respiratory distress syndrome (ARDS).MethodsComputerized searches were conducted in PubMed, EMbase, The Cochrane Library, Web of Science, CNKI, Wanfang Data, CBM, and VIP databases for randomized controlled trials (RCTs) on early mobilization in ARDS patients. The retrieval period was from the establishment of each database to September 30, 2025. Two reviewers independently assessed the quality of included literature and extracted data in accordance with Cochrane systematic review methodology. Meta-analysis was performed using RevMan 5.4.1 software for eligible studies.ResultsA total of 7 RCTs were included, consisting of 4 English and 3 Chinese articles. Meta-analysis showed that compared with conventional treatment, early mobilization significantly reduced the incidence of intensive care unit-acquired weakness (ICU-AW) [OR = 0.35, 95% CI (0.19,0.64), P = 0.0006] and delirium [OR = 0.51, 95% CI (0.28,0.91), P = 0.02], shortened the duration of mechanical ventilation [MD = −2.40,95% CI (-2.96,-1.84), P 
Free Newsletter

Clinical research that matters. Delivered to your inbox.

Join thousands of clinicians and researchers. No spam, unsubscribe anytime.